New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- Face the Facts: The CBD Hype Train Has Derailedon July 11, 2020 at 7:36 am
As many of you are probably aware, CBD is the nonpsychoactive cannabinoid that doesn't get users high, but is perceived to have medical benefits. Since its users won't get buzzed, there was the belief ...
- Sunny CBD Oil Reviews: New Full Spectrum Hemp Oil Formulaon July 11, 2020 at 2:00 am
Sunny CBD Oil Recent news broke about a trendy CBD oil that aims to help consumers obtain an active and healthy lifestyle that appeared across several online platforms. Given that CBD is a relatively ...
- Nearly Half of CBD Products Contained THC in Random FDA Testson July 10, 2020 at 12:19 pm
Of that group, only two products that claimed to contain CBD did not contain any CBD, a relatively high level of accuracy. (Seven products did not contain CBD, but also didn’t c ...
- Gelson’s Market adds new CBD product lineon July 10, 2020 at 11:58 am
San Diego-based Medical Marijuana Inc., parent of HempMeds, said this week that eight topical items have become available at three Gelson’s supermarkets, including Sherman Oaks, Santa Barbara and ...
- Researchers Note Potential of CBD as COVID-19 Treatment Optionon July 10, 2020 at 11:24 am
Cannabidiol (CBD) may be worth looking into as an option for the treatment of COVID-19, according to new research published in Brain, Behavior, and Immunity. The researchers,Siddappa N. Byrareddy from ...
- Iowa House approves medical cannabidiol changes, setting up clash with Senateon June 30, 2020 at 11:30 pm
DES MOINES — Iowans with some autistic conditions or post-traumatic stress disorder could be certified to participate in the state’s medical cannabidiol program under changes approved Tuesday ...
- While FDA Advances Work Related to Cannabidiol Products CBD Usage Rates are on the Riseon June 30, 2020 at 5:55 am
It said: "Findings in the report suggest that cannabidiol (CBD) has never been more popular in the United States… Relatively unknown only years ago, CBD has since exploded into a fast-growing ...
- Alexandra Dunhill makes her mark in the world of wellbeingon June 29, 2020 at 4:36 am
June 29, 2020 - 12:32 BST hellomagazine.com Alexandra Dunhill has launched Lady A, a range of female-focused cannabidiol (CBD) oil products, including skin creams, tinctures, vapes and gel caps ...
via Bing News